Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Complement. First of two parts.N Engl J Med. 2001; 344: 1058-1066
- The mannose-binding lectin: a prototypic pattern recognition molecule.Curr Opin Immunol. 2006; 18: 16-23
- The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction.J Biol Chem. 2010; 285: 7633-7644
- Inhibiting the complement system does not reduce injury in renal ischemia reperfusion.J Am Soc Nephrol. 2001; 12: 1383-1390
- Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells.J Clin Invest. 1986; 77: 762-767
- Complement: a key system for immune surveillance and homeostasis.Nat Immunol. 2010; 11: 785-797
- Role of C5a in inflammatory responses.Annu Rev Immunol. 2005; 23: 821-852
- The role of the anaphylatoxins in health and disease.Mol Immunol. 2009; 46: 2753-2766
- Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells.J Exp Med. 2013; 210: 257-268
- Cutting edge: receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells.J Immunol. 2013; 190: 5921-5925
- C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor.Kidney Int. 1999; 56: 1729-1736
- Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis.Blood. 2008; 112: 1759-1766
- Delayed graft function in the kidney transplant.Am J Transplant. 2011; 11: 2279-2296
- Natural IgM-mediated innate autoimmunity: a new target for early intervention of ischemia-reperfusion injury.Expert Opin Biol Ther. 2007; 7: 1575-1582
- Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction.Cardiovasc Res. 2010; 87: 618-627
- Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin.Am J Physiol Heart Circ Physiol. 2009; 297: H1853-H1859
- Complement recognition pathways in renal transplantation.J Am Soc Nephrol. 2017; 28: 2571-2578
- Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice.J Immunol. 2003; 170: 1517-1523
- Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.Transplantation. 2003; 75: 375-382
- C3a and C5a promote renal ischemia-reperfusion injury.J Am Soc Nephrol. 2012; 23: 1474-1485
- Local extravascular pool of C3 is a determinant of postischemic acute renal failure.FASEB J. 2006; 20: 217-226
- Donor brain death exacerbates complement-dependent ischemia/reperfusion injury in transplanted hearts.Circulation. 2013; 127: 1290-1299
- Complement dependence of murine costimulatory blockade-resistant cellular cardiac allograft rejection.Am J Transplant. 2017; 17: 2810-2819
- A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients.Am J Transplant. 2018; https://doi.org/10.1111/ajt.14767
- C1-esterase-inhibitor for primary graft dysfunction in lung transplantation.Transplantation. 2014; 97: 1185-1191
- Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant.Am J Transplant. 2018; 18: 2417-2428
- Therapeutic strategy with a membrane-localizing complement regulator to increase the number of usable donor organs after prolonged cold storage.J Am Soc Nephrol. 2006; 17: 1102-1111
- APT070 (mirococept), a membrane-localizing C3 convertase inhibitor, attenuates early human islet allograft damage in vitro and in vivo in a humanized mouse model.Br J Pharmacol. 2016; 173: 575-587
- A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.Trials. 2017; 18: 255
- Lack of efficacy of eculizumab for prevention of delayed graft function (DGF) in deceased donor kidney transplant recipients.Am J Transplant. 2018; 18: 674
- Local synthesis of complement component C3 regulates acute renal transplant rejection.Nat Med. 2002; 8: 582-587
- Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells.Immunity. 2008; 28: 425-435
- TLR-induced murine dendritic cell (DC) activation requires DC-intrinsic complement.J Immunol. 2017; 199: 278-291
- Immune cell-derived C3a and C5a costimulate human T cell alloimmunity.Am J Transplant. 2013; 13: 2530-2539
- Expression of complement components, receptors and regulators by human dendritic cells.Mol Immunol. 2011; 48: 1121-1127
- Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation.Immunity. 2013; 39: 1143-1157
- Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation.Mol Immunol. 2014; 58: 98-107
- Absence of signaling into CD4(+) cells via C3aR and C5aR enables autoinductive TGF-beta1 signaling and induction of Foxp3(+) regulatory T cells.Nat Immunol. 2013; 14: 162-171
- C5L2, a nonsignaling C5A binding protein.Biochemistry. 2003; 42: 9406-9415
- T cell expression of C5a receptor 2 augments murine regulatory T cell (TREG) generation and TREG-dependent cardiac allograft survival.J Immunol. 2018; 200: 2186-2198
- Complement and viral pathogenesis.Virology. 2011; 411: 362-373
- Complement in immune and inflammatory disorders: pathophysiological mechanisms.J Immunol. 2013; 190: 3831-3838
- Decay-accelerating factor: biochemistry, molecular biology, and function.Annu Rev Immunol. 1989; 7: 35-58
- Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection.J Immunol. 2008; 181: 4580-4589
- Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice.Am J Transplant. 2011; 11: 1397-1406
- Complement 5a receptor inhibition improves renal allograft survival.J Am Soc Nephrol. 2008; 19: 2302-2312
- C3a receptor regulates the CD8 T-cell alloresponse via intrinsic and extrinsic mechanisms.Am J Transplant. 2018; 18: 498
- Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response.J Immunol. 1998; 160: 5273-5279
- C3d of complement as a molecular adjuvant: bridging innate and acquired immunity.Science. 1996; 271: 348-350
- The allogeneic T and B cell response is strongly dependent on complement components C3 and C4.Transplantation. 2001; 72: 1310-1318
- Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation.J Immunol. 2007; 179: 4451-4463
- Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms.Curr Opin Organ Transplant. 2014; 19: 33-40
- The role of complement in antibody-mediated rejection in kidney transplantation.Nat Rev Nephrol. 2012; 8: 670-678
- Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-kappaB signaling in endothelial cells.Circulation. 2013; 128: 2504-2516
- Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients.Am J Transplant. 2011; 11: 2405-2413
- The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection.Am J Transplant. 2009; 9: 231-235
- Report of the inefficacy of eculizumab in two cases of severe antibody-mediated rejection of renal grafts.Transplantation. 2014; 98: 1056-1059
- Plasma-derived C1 esterase inhibitor for acute antibody-mediated rejection following kidney transplantation: results of a randomized double-blind placebo-controlled pilot study.Am J Transplant. 2016; 16: 3468-3478
- Complement polymorphisms in kidney transplantation: critical in graft rejection?.Am J Transplant. 2017; 17: 2000-2007
- Impact of complement component 3/4/5 single nucleotide polymorphisms on renal transplant recipients with antibody-mediated rejection.Oncotarget. 2017; 8: 94539-94553
- Upregulation of CD59: potential mechanism of accommodation in a large animal model.Transplantation. 2009; 87: 1308-1317
- Association between promoter polymorphisms in CD46 and CD59 in kidney donors and transplant outcome.Front Immunol. 2018; 9: 972
- A promoter polymorphism in the CD59 complement regulatory protein gene in donor lungs correlates with a higher risk for chronic rejection after lung transplantation.Am J Transplant. 2016; 16: 987-998
- Complement-binding anti-HLA antibodies and kidney-allograft survival.N Engl J Med. 2013; 369: 1215-1226
- Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients.J Heart Lung Transplant. 2013; 32: 98-105
- Acute antibody-mediated rejection after lung transplantation.J Heart Lung Transplant. 2013; 32: 1034-1040
- Evaluation of C1q status and titer of de novo donor-specific antibodies as predictors of allograft survival.Am J Transplant. 2017; 17: 703-711
- Detection of a soluble form of the complement membrane attack complex inhibitor CD59 in plasma after acute myocardial infarction.Scand J Immunol. 2000; 52: 411-414
- Soluble CD59 is a novel biomarker for the prediction of obstructive chronic lung allograft dysfunction after lung transplantation.Sci Rep. 2016; 6: 26274
- Plasma C4d+ endothelial microvesicles increase in acute antibody-mediated rejection.Transplantation. 2017; 101: 2235-2243
- Immune complexome analysis of antigens in circulating immune complexes from patients with acute cellular rejection after living donor liver transplantation.Transpl Immunol. 2018; 48: 60-64
- Targeting the complement cascade: novel treatments coming down the pike.Kidney Int. 2016; 90: 746-752
Article info
Publication history
Published online: December 19, 2018
Footnotes
Disclosures: The authors have nothing to disclose.
Funding: The work was supported by NIH, NIAID grants R01 AI071185 and R01 AI132405 awarded to P.S. Heeger and K08 AI135101 to N.H. Chun.
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.
